Ad is loading...
VISVX
Price
$50.61
Change
+$0.82 (+1.65%)
Updated
Nov 21 closing price
VSIIX
Price
$50.70
Change
+$0.83 (+1.66%)
Updated
Nov 21 closing price
Ad is loading...

VISVX vs VSIIX

Header iconVISVX vs VSIIX Comparison
Open Charts VISVX vs VSIIXBanner chart's image
Vanguard Small Cap Value Index I
Price$50.61
Change+$0.82 (+1.65%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$50.70
Change+$0.83 (+1.66%)
VolumeN/A
CapitalizationN/A
VISVX vs VSIIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VISVX vs. VSIIX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VISVX is a Buy and VSIIX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX (57.6B) and VSIIX (57.6B) have equal amount of cash in the bank . VSIIX pays higher dividends than VISVX: VSIIX (2.02) vs VISVX (1.90). VISVX was incepted earlier than VSIIX: VISVX (27 years) vs VSIIX (25 years). VISVX (16.00) and VSIIX (16.00) have comparable annual turnover. VISVX has a lower initial minimum investment than VSIIX: VISVX (3000) vs VSIIX (5000000). VSIIX (30.12) and VISVX (30.04) have marching annual gain over last year. VSIIX (62.33) and VISVX (62.14) have equivalent 5 years return.
VISVXVSIIXVISVX / VSIIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years25 years-
Gain YTD17.71217.792100%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets57.6B57.6B100%
Annual Yield % from dividends1.902.0294%
Returns for 1 year30.0430.12100%
Returns for 3 years16.9217.0099%
Returns for 5 years62.1462.33100%
Returns for 10 years109.83110.5199%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics